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Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56 S23CD69þCD4þ T cells in adipose tissue (r¼0.470, p¼0.27). Co-staining for
different cytokines upon polyclonal stimulation revealed that IL-6-
secreting CD4þ T cells are distinct from the T cells secreting other
cytokines such as IFNg and TNFa. In addition, chemokine receptor
expression revealed that these IL6 producing T cells could not be
categorized as conventional T helper 1 (Th1), Th2, Th17 or Tfh cells.
These data indicate that IL6-secreting T cells are a distinct population of
T cells. Finally, we have also studied whether these IL6 producing T cells
are also present in other tissues. Indeed, we have found these cells also
in sc adipose tissues and synovium of OA patients, but only at low
frequencies in blood.
Conclusions: In conclusion, we have found a novel population of CD4þ
T cells which secrete IL-6 directly ex vivo and are in an activated state,
indicating that these CD4þ T cells might recognize adipose tissue anti-
gens and could be involved in the inﬂammatory processes present in
human adipose tissue. Moreover, they are a source of IL-6 in the OA
joint, thereby potentially contributing to joint inﬂammation.
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INDUCTION OF NERVE GROWTH FACTOR EXPRESSION AND RELEASE
BY MECHANICAL AND INFLAMMATORY STIMULI IN CHONDROCYTES:
POSSIBLE INVOLVEMENT IN OA PAIN
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Purpose: Nerve growth factor (NGF) level is increased in OA joint and is
involved in pain associated with OA. Stimuli responsible for NGF stim-
ulation in chondrocytes are unknown. We investigated whether
mechanical stress and pro-inﬂammatory cytokines may inﬂuence NGF
synthesis by chondrocytes.
Methods: Primary cultures of human OA chondrocytes, newborn
mouse articular chondrocytes or cartilage explants were stimulated by
increasing amounts of IL-1b, prostaglandin E2 (PGE2), visfatin/NAMPT
(nicotinamide phosphoribosyltransferase) or by cyclic mechanical
compression (0.5 Hz, 1 MPa). Before stimulation, chondrocytes were
pretreated with indomethacin, Apo866, a speciﬁc inhibitor of NAMPT
enzymatic activity, or transfected by siRNA targeting visfatin/NAMPT.
mRNA NGF levels were assessed by real-time quantitative PCR and NGF
released into media was determined by ELISA.
Results: Unstimulated human and mouse articular chondrocytes
expressed low levels of NGF (19.2  8.7 pg/mL, 13.5  1.0 pg/mL and 4.4
 0.8 pg/mL/mg tissue for human and mouse articular chondrocytes
and costal explants, respectively). Mechanical stress induced NGF
release in conditioned media. When stimulated by IL-1b or visfatin/
NAMPT, a pro-inﬂammatory adipokine produced by chondocytes in
response to IL-1b, a dose-dependent increase in NGF mRNA expression
and NGF release in both human and mouse chondrocyte conditioned
media was observed. Visfatin/NAMPT is also an intracellular enzyme
acting as the rate-limiting enzyme of the generation of NAD. The
expression of NGF induced by visfatin/NAMPTwas inhibited by Apo866,
whereas IL-1b-mediated NGF expression was not modiﬁed by siRNA
targeting visfatin/NAMPT. Interestingly, PGE2, which is produced by
chondrocytes in response to IL-1b and visfatin/NAMPT, did not stim-
ulate NGF production. Consistently, indomethacin, a cyclooxygenase
inhibitor, did not counteract IL-1b-induced NGF production.
Conclusions: These results suggest that the overexpression of visfatin/
NAMPT and IL-1b in OA joint and the increased mechanical loading of
cartilage may mediate OA pain via the stimulation of NGF expression
and release by chondrocytes.
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THE IMMUNOMODULATORY PROPERTIES OF MESENCHYMAL
STROMAL CELLS ISOLATED FROM THE SYNOVIAL FLUID OF HUMAN
OSTEOARTHRITIC JOINTS
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France; k INSERM UMRS 1064, ITUN, Nantes, FrancePurpose: OA is a degenerative joint disease accompanied by inﬂam-
mation, loss of cartilaginous matrix, ﬁbrillation, formation of ﬁssures,
and ultimately complete loss of the cartilage surface. Current pharma-
cological therapies for OA provide, at best, symptomatic relief from pain
but fail to prevent cartilage damage and subsequent destruction of
other joints tissues. Facing this situation, Mesenchymal Stromal Cells
(MSC) have generated a recent signiﬁcant medical consideration since
they have the ability to differentiate into various tissues (including
cartilage, bone, fat.) and exhibit tissue-regenerative properties.
Moreover, MSC display immunomodulatory properties that can be
instrumental for the treatment of inﬂammation-associated OA symp-
toms. Whereas adherent cells from the synovial ﬂuid (SFAC) of osteo-
arthritic joints have been proposed to meet the criteria of MSC (Jones,
English et al. 2004), their immunomodulatory properties have not yet
been characterized. With respect to the potential interest of isolating
some multipotent and immuno-competent cells from OA joints, the
present work aims at comparing the immunomodulatory properties of
SFAC with those of MSC isolated from bone marrow (BM-MSC) and
adipose tissue (ASC).
Materials and methods: Human BM-MSC and ASC were obtained from
healthy volunteers and human SFAC were harvested from OA patients
undergoing knee surgery, after consent. Flow cytometric (FACS) analysis
was performed to evaluate the expression of surface markers (CD14,
CD34, CD 44, CD 45, CD73, CD90, CD 105, CD166, HLA-ABC, HLA-DR) in
BM-MSC, ASC and SFAC. SFAC were characterized for their ability to
form colony by CFU-F assay andmultipotency. Themultipotency of SFAC
was characterized by evaluating their ability to differentiate towards
the adipogenic, osteogenic and chondrogenic lineage under speciﬁc
inductive culture conditions. Cell differentiation was monitored at the
level of mRNA by real time-PCR (ALPL, RUNX2, COL1A1, COL2A1, ACAN,
SOX9, COMP, PPARg) and by speciﬁc biochemical analysis: alkaline
phosphatase (ALP) activity and immunohistochemical staining: oil red
O, alizarin red, alcian blue and type II collagen. For immunomodulation
experiments, human allogeneic T lymphocytes were collected and co-
cultured with the various MSC. MSC were stimulated or not, prior to co-
culture, with Interferon g (IFN-g) and then analyzed by FACS for the
expression of HLA-ABC and HLA-DR. Proliferation and IFN-g secretion
by T lymphocytes were measured by FACS after co-culture of MSC and T
lymphocytes with different increasing ratios.
Results: SFAC were positive for MSC surface markers and negative for
hematopoietic cell markers. SFAC also exhibited proliferation and col-
ony-forming abilities. Additionally, SFAC were able to differentiate
towards the chondro-, osteo- and adipogenic lineages. Human T lym-
phocytes were not activated by MSC regarding proliferation and IFN-g
secretion suggesting that MSC failed to exhibit immuno-stimulating
properties. When cultured with activated T lymphocytes, MSC were
able to decrease IFN-g secretion by CD4þ and CD8þT lymphocytes and
inhibited their proliferation in a dose-dependent manner. Pre-stim-
ulation of MSC with IFN-g results in an increase in their immuno-reg-
ulatory properties. Data generated with SFAC were comparable to those
obtained with BM-MSC and ASC highlighting that SFAC exhibited
immuno-modulatory properties.
Conclusion: Our results demonstrate that the synovial ﬂuid of OA joints
contains a very accessible population of multipotent MSC. Our data also
indicate that SFAC exhibit immunosuppressive properties making
synovial ﬂuid a promising cell source for cell therapy in osteoarthritis.
Further experiments are under investigation with an increased number
of patients (clinical trial “Arthrostem” NCT01879046) to identify the
molecular mechanisms involved in the immunomodulatory properties
of SFAC.
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IDENTIFICATION OF SYNOVIAL GENES AND PATHWAYS ASSOCIATED
WITH DISEASE PROGRESSION IN A COHORT OF EARLY
OSTEOARTHRITIS PATIENTS (CHECK)
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Purpose: Over 50% of osteoarthritis (OA) patients show synovial
inﬂammation, even relatively early during the disease. However, if and
how this synovial activation contributes to the irreversible joint path-
ology that characterizes OA, is not known. In the present study we used
